轩竹生物科技股份有限公司（证券简称：轩竹生物-B，股票代码：02575）于2026年5月7日披露的2026年4月止股份变动月报表显示，公司本月未发生新增发行、股份购回或注销等情况，股本结构保持稳定。
截至2026年4月30日，公司 H 股已发行股份数为160,701,996股，与上月持平；未上市股份数量为357,245,794股，与上月相同；两类股份合计517,947,790股，本月公司注册股本及已发行股本总数均未发生变化。
月报还显示，公司本月无股份期权及股权激励计划变动，无可换股票据或其他协议、安排导致的股份变动。该公司同时确认符合相关公众持股量要求，并已遵守香港联合交易所有限公司《上市规则》及相关法律法规。
本公告由联席公司秘书何成明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.